Regular Article
A Selective Agonist Affinity Label for A3 Adenosine Receptors

https://doi.org/10.1006/bbrc.1994.2220Get rights and content

Abstract

A newly synthesized, chemically reactive adenosine derivative, N6-(3-isothiocyanatobenzyl)adenosine-5′-N-methyluronamide, was found to bind selectively to A3 receptors. Ki values for this isothiocyanate derivative in competition binding at rat brain A1, A2a, and A3 receptors were 145, 272 and 10.0 nM, respectively. A preincubation with this derivative resulted in irreversible inhibition of radioligand binding at rat A3 receptors in membranes of transfected CHO cells or RBL-2H3 mast cells, but not at rat A1 or A2a receptors. The loss of binding sites for 0.1 nM [125I]N6-(4-aminobenzyl)adenosine-5′-N-methyluronamide, a high affinity A3 receptor radioligand, in transfected CHO cell membranes was concentration-dependent with an IC50 of 50 nM. No change was observed in the Kd value of the remaining A3 receptor sites. The inhibition was also insensitive to theophylline (1 mM), consistent with the pharmacology of rat A3 receptors. Structurally similar adenosine analogues lacking the chemically reactive isothiocyanate group failed to irreversibly inhibit A3-binding.

References (0)

Cited by (27)

  • Role of adenosine A<inf>3</inf> receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration

    2007, Biochemical Pharmacology
    Citation Excerpt :

    A3 receptors have a widespread distribution in the rat brain [3] and in the hippocampus are preferentially expressed on nerve terminals [4,5]. The expression of A3 receptors in the brain is lower than that of other adenosine receptor subtypes [6], and the affinity for adenosine, calculated from binding experiments in rat brain membranes (6.5 μM [2]), is lower than that of A1[7] and A2A[8] receptors. However, during ischemic conditions in vivo[9] and in vitro[10] adenosine extracellular concentrations may be sufficiently high to activate adenosine A3 receptors, which may play a role in brain ischemia (see Refs. [11,12]).

  • Discriminative disulfide-bonding affinity labeling of opioid receptor subtypes

    2001, Journal of Biochemical and Biophysical Methods
  • 2 The Adenosine A<inf>3</inf> Receptor and its Ligands

    2001, Progress in Medicinal Chemistry
View all citing articles on Scopus
View full text